Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting

Clinical trial NCT04128501 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04128501
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Bilineal Leukemia Acute Biphenotypic Leukemia Acute Myeloid Leukemia Mixed Phenotype Acute Leukemia T Acute Lymphoblastic Leukemia Therapy-Related Acute Myeloid Leukemia

Start date: 2020-05-05
Primary completion: 2026-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.